Open AccessCoronavirus Disease-2019 in Children with Primary Kidney Disease: A Case series
Author(s) -
Ashwin Meshram,
Kinnari Vala,
Arindam Saha,
Himanshu V. Patel,
Vivek Kute,
Dinesh N. Gera
Publication year - 2021
Publication title -
saudi journal of kidney diseases and transplantation/našrat amraḍ wa zira'aẗ al-kulaẗ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 30
eISSN - 2320-3838
pISSN - 1319-2442
DOI - 10.4103/1319-2442.318527
Subject(s) - medicine , azithromycin , kidney disease , nephrotic syndrome , disease , respiratory distress , pediatrics , pandemic , intensive care medicine , immunology , covid-19 , infectious disease (medical specialty) , surgery , antibiotics , microbiology and biotechnology , biology
Underlying comorbid illness is a known risk factor for severe coronavirus disease-2019 (COVID-19). Clinical course of COVID-19 in children with primary kidney disease is not well understood. We present the clinical profile and management of COVID-19 in three children at a COVID hospital in India. These children had nephrotic syndrome, hemolytic uremic syndrome, and chronic kidney disease, respectively. The first two were immunosuppressed, mandating to stop their immunosuppressive medications temporarily. Both had mild course of illness. Third child presented with respiratory distress requiring oxygen support, falling into moderate disease. Renal functions were normal in all of them. They all responded well to oral azithromycin and supportive management. None of them received chloroquine, corticosteroids, or monoclonal antibodies. All three recovered without complications.